
Every seven minutes, a woman in India dies of cervical cancer.
Read that again. Every. Seven. Minutes.
Cervical cancer claims over 77,000 lives in India every single year — more than any other country in the world. India accounts for over 23% of all global cervical cancer deaths. And the most heartbreaking part of this tragedy? Cervical cancer is one of the most preventable and most treatable cancers in existence — when it is caught early.
The reason so many Indian women die from cervical cancer is not because it is untreatable. It is because it is undetected — until it is too late. A combination of lack of awareness, cultural stigma around reproductive health, low screening rates (just 2% of Indian women are regularly screened), and limited access to healthcare in rural areas means that most Indian women are diagnosed at an advanced stage.
This needs to change. And it starts with knowledge.
This guide covers everything every Indian woman needs to know about cervical cancer — what it is, why it happens, what the symptoms are, how it is diagnosed, what treatment looks like, and how to prevent it entirely. Because for cervical cancer, prevention and early detection are not just possibilities — they are proven realities that save lives every day.
What Is Cervical Cancer?
Cervical cancer starts in the cervix — the narrow, lower part of the uterus (womb) that connects to the vagina. The cervix is sometimes called the “neck of the womb.” It plays a critical role in reproduction — it is the gateway between the uterus and the vagina.
Cervical cancer develops when cells in the cervix undergo abnormal changes and begin to grow out of control. These abnormal cell changes typically develop slowly over many years — first as pre-cancerous changes called cervical intraepithelial neoplasia (CIN) or dysplasia — before eventually becoming cancer if left untreated.
This slow development is actually the reason cervical cancer is so preventable — because there is a significant window of time in which these pre-cancerous changes can be detected through screening and treated before they become cancer.
The HPV Connection — Why Almost All Cervical Cancer Is Caused By One Virus
This is the single most important fact about cervical cancer:
Persistent infection with high-risk types of Human Papillomavirus (HPV) is responsible for approximately 95% of all cervical cancer cases.
HPV is one of the most common viruses in the world. It is estimated that most sexually active people will be infected with HPV at some point in their lives. In India, a meta-analysis reported an overall HPV infection rate of approximately 30% among women tested.
But here is the critical distinction: Most HPV infections are harmless and clear on their own — the body’s immune system eliminates them without any symptoms or lasting effects. The vast majority of women who get HPV will never develop cervical cancer.
The problem arises when a high-risk strain of HPV — particularly HPV 16 and HPV 18, which together cause approximately 70% of cervical cancers — persists in the body for years and causes the cervical cells to undergo abnormal changes that can eventually turn cancerous.
There are over 200 known strains of HPV. Around 14 strains are classified as high-risk (oncogenic) — meaning they have the potential to cause cancer. The key high-risk strains in India include HPV 16, 18, 31, 33, 45, 52 and 58.
The most important takeaway: Because HPV causes almost all cervical cancer, and because we have an effective vaccine against HPV, cervical cancer is theoretically one of the only cancers that can be almost entirely prevented through vaccination and screening.
Types of Cervical Cancer
1. Squamous Cell Carcinoma — Most Common (70-80%)
This is by far the most common type of cervical cancer. It develops in the squamous cells — the flat, thin cells that line the outer surface of the cervix (the ectocervix). It typically develops at the junction where the ectocervix meets the endocervix — an area called the transformation zone where HPV infections most commonly establish themselves.
2. Adenocarcinoma (15-25%)
Adenocarcinoma develops in the glandular cells — the column-shaped cells that line the inner canal of the cervix (the endocervix). Adenocarcinoma has become relatively more common over recent decades and can be harder to detect through standard Pap smear screening because of the location of these cells. It is more often associated with HPV 18.
3. Adenosquamous Carcinoma (Mixed Type)
A less common type that contains features of both squamous cell carcinoma and adenocarcinoma. It behaves more aggressively than pure squamous cell carcinoma.
4. Other Rare Types
Including small cell carcinoma, neuroendocrine tumours and clear cell carcinoma — each accounting for a very small percentage of cases and requiring specialised treatment approaches.
Warning Signs — Symptoms of Cervical Cancer
One of the most dangerous characteristics of cervical cancer is that early-stage cervical cancer typically causes no symptoms at all. This is precisely why regular screening — not waiting for symptoms — is the only reliable way to detect it early.
As the cancer grows and progresses, symptoms begin to appear. By the time most women in India seek medical attention, the cancer has already reached an advanced stage.
The Primary Warning Signs
Abnormal Vaginal Bleeding This is the most common and important symptom of cervical cancer. Watch for:
- Bleeding between periods (intermenstrual bleeding)
- Bleeding after sexual intercourse (post-coital bleeding)
- Bleeding after menopause in women who have passed menopause
- Periods that are heavier or longer than usual
- Spotting or light bleeding at any unexpected time
Unusual Vaginal Discharge A watery, bloody or foul-smelling vaginal discharge that is different from normal discharge. This can be continuous or intermittent. The discharge may be heavier than usual and may have an unpleasant odour.
Pelvic Pain Persistent pain in the pelvis — in the lower abdomen — that is not related to the menstrual cycle. This can range from a dull ache to sharp pain and may be felt during or after sexual intercourse.
Pain During Sexual Intercourse (Dyspareunia) Pain during sex can be one of the earlier symptoms of cervical cancer as the tumour makes the cervix sensitive and tender.
Symptoms of Advanced Cervical Cancer
As the cancer grows and spreads to nearby organs and tissues, additional symptoms may develop:
- Back pain or leg pain — from tumour pressing on nerves
- Swelling of one or both legs — from tumour blocking lymph vessels
- Difficulty urinating or blood in urine — if cancer spreads to the bladder
- Difficulty with bowel movements or blood in stool — if cancer spreads to the rectum
- Loss of bladder or bowel control — in advanced cases
- Significant weight loss and fatigue
- Kidney failure — in very advanced cases from ureteral obstruction
Critical message for Indian women: Do not wait for symptoms before seeking a check-up. Pre-cancerous changes and early cervical cancer have NO symptoms. Routine Pap smear and HPV testing is the only way to detect it before symptoms appear. Once symptoms like abnormal bleeding develop, the cancer may already be at Stage 2 or beyond.
Causes and Risk Factors of Cervical Cancer
Primary Cause — HPV Infection
As established, persistent infection with high-risk HPV strains is the root cause of approximately 95% of cervical cancers. However, not every woman with HPV develops cervical cancer — other factors determine whether an HPV infection progresses to cancer.
Risk Factors That Increase the Chance of HPV Progressing to Cervical Cancer
Smoking Smoking significantly increases the risk of cervical cancer in women with HPV infection. Tobacco byproducts are found in cervical mucus, where they damage cervical cells and weaken the local immune response — making it easier for HPV to cause cellular changes.
Weakened Immune System Women with HIV/AIDS, those on long-term immunosuppressive medications (such as after organ transplant), or those with other conditions that weaken immunity are significantly more vulnerable to HPV-related cancer development because their immune system cannot suppress the virus effectively.
Long-term Use of Oral Contraceptives Women who have used oral contraceptive pills for five or more years have a modestly elevated risk of cervical cancer. This risk decreases after stopping the pill and returns to normal over time.
Multiple Full-Term Pregnancies Having three or more full-term pregnancies is associated with increased cervical cancer risk. The hormonal changes during pregnancy and exposure of the cervix during delivery may play a role.
Early First Pregnancy Women who had their first full-term pregnancy before the age of 17 have a higher risk of cervical cancer than those who waited until age 25 or older.
Multiple Sexual Partners Having multiple sexual partners increases the risk of HPV exposure — though it is critical to note that HPV can be contracted even with a single partner, and the cancer is caused by the virus, not by any personal behaviour or character.
Socioeconomic and Healthcare Access Factors In India, limited access to screening — particularly in rural and semi-urban areas — means pre-cancerous changes go undetected and untreated. Cervical cancer disproportionately affects women from lower socioeconomic backgrounds due to the unaffordability of vaccines, lack of early detection through screening, and other access barriers.
Lack of HPV Vaccination Women who have not received the HPV vaccine are at higher risk, as the vaccine provides protection against the high-risk strains most likely to cause cancer.
How Is Cervical Cancer Diagnosed?
Screening Tests — Detecting It Before It Becomes Cancer
Pap Smear (Pap Test) The Pap smear collects cells from the cervix and examines them under a microscope for abnormalities. It is the most widely used cervical cancer screening test globally. Indian guidelines recommend Pap smears every 3 years for women aged 21-65.
HPV DNA Test The HPV DNA test checks whether high-risk strains of HPV are present in cervical cells. The WHO recommends HPV DNA testing as the primary cervical screening method — it can detect HPV infection before any abnormal cell changes even develop. It is recommended every 5 years for women aged 30 and above.
Co-testing A combination of Pap smear and HPV testing together — the most comprehensive screening approach.
VIA (Visual Inspection with Acetic Acid) A simpler, low-cost screening method used widely in India’s rural health programmes — where acetic acid (vinegar) is applied to the cervix and abnormal areas turn white, visually identifying pre-cancerous changes.
Diagnostic Tests After an Abnormal Screening Result
| Test | Purpose | Approximate Cost in Bangalore |
|---|---|---|
| Colposcopy | Magnified visual examination of the cervix after abnormal Pap/HPV result | ₹2,000 – ₹5,000 |
| Cervical Biopsy | Tissue sample from abnormal area — confirms or rules out cancer | ₹3,000 – ₹8,000 |
| LEEP/LLETZ | Loop excision of the transformation zone — both diagnostic and therapeutic | ₹8,000 – ₹20,000 |
| Cone Biopsy | Surgical removal of a cone-shaped piece of cervical tissue for analysis | ₹15,000 – ₹30,000 |
| MRI Pelvis | Assess tumour size, local spread to parametrium and lymph nodes | ₹5,000 – ₹15,000 |
| CT Scan | Assess spread to lymph nodes and distant organs | ₹4,000 – ₹10,000 |
| PET-CT Scan | Full-body staging — detects distant metastases | ₹15,000 – ₹28,000 |
| HPV DNA Test | Identify specific HPV strain | ₹1,500 – ₹4,000 |
| Cystoscopy | Check if cancer has spread to the bladder | ₹5,000 – ₹12,000 |
| Sigmoidoscopy/Proctoscopy | Check if cancer has spread to the rectum | ₹4,000 – ₹10,000 |
Stages of Cervical Cancer
The staging of cervical cancer follows the FIGO (International Federation of Gynaecology and Obstetrics) system and determines the extent of the disease.
| Stage | Description | 5-Year Survival Rate |
|---|---|---|
| Stage 1 | Cancer confined to the cervix | 80 – 93% |
| Stage 1A | Microscopic invasion — detected only under microscope | 93% |
| Stage 1B | Visible tumour confined to cervix | 80% |
| Stage 2 | Cancer spread beyond cervix but not to pelvic wall or lower vagina | 58 – 75% |
| Stage 2A | Cancer spread to upper two-thirds of vagina | 75% |
| Stage 2B | Cancer spread to tissue beside cervix (parametrium) | 58% |
| Stage 3 | Cancer spread to lower vagina or pelvic wall, or causing kidney problems | 32 – 35% |
| Stage 4 | Cancer spread to bladder, rectum or distant organs | 15 – 16% |
The critical India fact: The majority of Indian women are diagnosed at Stage 3 or Stage 4 — when survival rates drop dramatically. Early detection at Stage 1 gives a survival rate above 90%.
Treatment Options for Cervical Cancer in Bangalore
Treatment is planned by a multidisciplinary team including a gynaecologic oncologist, radiation oncologist, medical oncologist, pathologist and radiologist. The treatment approach depends on the stage, the tumour size, whether the woman wishes to preserve fertility, and her overall health.
1. Surgery
Surgery is the primary treatment for early-stage cervical cancer (Stages 1A to 2A).
Types of cervical cancer surgery:
Simple Hysterectomy Removal of the uterus and cervix, without removing the lymph nodes or parametrium. Used for Stage 1A1 — the earliest microscopic stage.
Radical Hysterectomy (Wertheim’s Hysterectomy) Removal of the uterus, cervix, upper vagina, parametrium (tissue beside the cervix), and pelvic lymph nodes. This is the most common surgical treatment for early-stage cervical cancer. It is a major surgery but offers excellent cure rates for Stage 1B and Stage 2A disease.
Robotic or Laparoscopic Radical Hysterectomy Minimally invasive versions of radical hysterectomy — available at leading centres in Bangalore including Apollo and HCG. Results in less pain, smaller incisions, less blood loss and faster recovery compared to open surgery.
Trachelectomy (Fertility-Sparing Surgery) For carefully selected young women with Stage 1A or small Stage 1B tumours who wish to preserve their ability to have children — the cervix is removed while the uterus is preserved. This is available at specialist centres in Bangalore.
Pelvic Exenteration For recurrent cervical cancer — a major surgery involving removal of the cervix, uterus, vagina and possibly the bladder and/or rectum. Reserved for specific situations of recurrent disease.
Cone Biopsy / LEEP For pre-cancerous lesions (CIN) and very early Stage 1A1 disease — a cone-shaped section of the cervix is removed, both removing the abnormal area and preserving the cervix.
2. Radiation Therapy — The Backbone of Cervical Cancer Treatment
Radiation therapy is central to cervical cancer treatment — particularly for Stage 2B and beyond. It is also used after surgery if high-risk features are present.
External Beam Radiation Therapy (EBRT) High-energy X-rays delivered to the pelvis from outside the body — targeting the cervix, uterus, parametrium and pelvic lymph nodes. Typically given over 5-6 weeks, 5 days a week.
Brachytherapy (Internal Radiation Therapy) This is a critical component of cervical cancer treatment that gives it a significant advantage. In brachytherapy, a radioactive source is placed directly inside or very close to the tumour — delivering a very high dose of radiation precisely to the cancer while minimising exposure to surrounding organs like the bladder and rectum.
Brachytherapy is almost always combined with EBRT for cervical cancer treatment from Stage 2B onwards. Bangalore’s top cancer centres — HCG, Apollo, Manipal — all have advanced brachytherapy capabilities.
Advanced Radiation Techniques Available in Bangalore:
- IMRT (Intensity Modulated Radiation Therapy) — shapes the radiation precisely to the tumour
- IGRT (Image Guided Radiation Therapy) — uses imaging to precisely target treatment each session
- 3D-CRT (3D Conformal Radiation Therapy)
- Elekta Microselectron Digital — advanced brachytherapy system at HCG
- CyberKnife — robotic radiosurgery for recurrent disease
3. Chemotherapy
Chemotherapy is most commonly used alongside radiation therapy (chemoradiation) for cervical cancer — not typically as standalone treatment.
The standard chemotherapy drug used with radiation for cervical cancer is Cisplatin — given weekly during the course of radiation. This combination (Cisplatin + radiation + brachytherapy) is the standard of care for Stage 2B to Stage 4A cervical cancer.
For metastatic (Stage 4B) or recurrent disease, combination chemotherapy regimens are used — typically Cisplatin with Paclitaxel, sometimes with Bevacizumab (targeted therapy).
4. Targeted Therapy
Bevacizumab (Avastin) is a targeted therapy drug that cuts off the tumour’s blood supply by blocking a protein called VEGF. It is used in combination with chemotherapy for metastatic or recurrent cervical cancer and has shown improved survival in these settings.
Research into other targeted therapies for cervical cancer is ongoing, including drugs targeting the PI3K/AKT/mTOR pathway.
5. Immunotherapy
Immunotherapy is rapidly becoming an important tool in cervical cancer treatment.
Pembrolizumab (Keytruda) — a PD-1 checkpoint inhibitor — is now approved for cervical cancer in certain settings:
- For tumours that express PD-L1
- For patients with microsatellite instability-high (MSI-H) tumours
- In combination with chemotherapy for first-line treatment of persistent, recurrent or metastatic cervical cancer
Tisotumab Vedotin — an antibody-drug conjugate specifically targeting a protein expressed on cervical cancer cells — has shown promising results in recurrent disease and is available at advanced centres.
6. Palliative Care
For advanced or recurrent cervical cancer where cure is not the goal, expert palliative care focuses on controlling symptoms — particularly pain, bleeding and urinary issues — and maintaining the best possible quality of life.
HPV Vaccination — How to Prevent Cervical Cancer Entirely
This is the most powerful weapon available against cervical cancer — and it is available in India.
HPV vaccines protect against the high-risk strains of HPV that cause the majority of cervical cancers.
Vaccines Available in India
| Vaccine | Strains Covered | Best For |
|---|---|---|
| Cervarix (2-valent) | HPV 16, 18 | Girls — cervical cancer protection |
| Gardasil (4-valent) | HPV 6, 11, 16, 18 | Girls and boys — cervical cancer + genital warts |
| Gardasil 9 (9-valent) | HPV 6, 11, 16, 18, 31, 33, 45, 52, 58 | Broadest protection available |
| Cervavac (India-made, 4-valent) | HPV 6, 11, 16, 18 | India’s own affordable HPV vaccine |
Who Should Get Vaccinated?
Most effective: Girls aged 9-14 — before sexual debut, when the immune response is strongest and only 2 doses are needed.
Also beneficial: Females aged 15-26 — 3 doses required. Still highly effective.
Up to age 45: Even older women can benefit, especially if not previously exposed to all vaccine strains.
Males: HPV vaccination is also recommended for boys and men — HPV causes not only cervical cancer but also cancers of the throat, penis, anus and vulva.
Government HPV Vaccination in India
The Government of India launched the national HPV vaccination programme in February 2023 — targeting girls aged 9-14 through school-based immunisation. The Cervavac vaccine (made by Serum Institute of India) is available at significantly subsidised prices under government programmes.
Cost of HPV vaccine in India (private sector):
- Gardasil 9: ₹3,000 – ₹4,000 per dose (3 doses = ₹9,000 – ₹12,000)
- Cervavac: ₹2,000 per dose (subsidised/government programmes available)
Cervical Cancer Treatment Cost in Bangalore — 2026
Surgery Costs
| Procedure | Estimated Cost |
|---|---|
| Simple Hysterectomy | ₹1,50,000 – ₹3,00,000 |
| Radical Hysterectomy (open) | ₹2,50,000 – ₹5,00,000 |
| Laparoscopic/Robotic Radical Hysterectomy | ₹4,00,000 – ₹8,00,000 |
| Trachelectomy (fertility-sparing) | ₹3,00,000 – ₹6,00,000 |
| Cone Biopsy / LEEP | ₹15,000 – ₹40,000 |
Radiation Therapy Costs
| Type | Estimated Cost |
|---|---|
| External Beam Radiation (full course, 25-28 fractions) | ₹1,50,000 – ₹3,00,000 |
| Brachytherapy (intracavitary) | ₹80,000 – ₹2,00,000 |
| EBRT + Brachytherapy combined | ₹2,50,000 – ₹5,00,000 |
Chemotherapy Costs
| Type | Estimated Cost |
|---|---|
| Weekly Cisplatin (concurrent with radiation) | ₹5,000 – ₹15,000 per session |
| Full course concurrent chemoradiation | ₹80,000 – ₹2,00,000 |
| Palliative chemotherapy (per cycle) | ₹30,000 – ₹80,000 |
Complete Treatment Package
| Treatment Package | Estimated Total Cost |
|---|---|
| Early stage (Surgery alone) | ₹2,50,000 – ₹8,00,000 |
| Stage 2B-3 (Chemoradiation + Brachytherapy) | ₹3,00,000 – ₹8,00,000 |
| Advanced (Surgery + Chemoradiation) | ₹5,00,000 – ₹12,00,000 |
| Metastatic (Chemo + Targeted + Immunotherapy) | ₹8,00,000 – ₹20,00,000 |
India vs World — Cost Comparison
| Country | Cervical Cancer Treatment Cost |
|---|---|
| United States | USD 50,000 – USD 2,00,000 (₹42 lakh – ₹1.7 crore) |
| United Kingdom | GBP 30,000 – GBP 80,000 (₹33 lakh – ₹88 lakh) |
| Singapore | USD 25,000 – USD 70,000 (₹21 lakh – ₹59 lakh) |
| Bangalore, India | ₹2,50,000 – ₹12,00,000 |
Bangalore offers savings of 70-85% compared to Western countries — with world-class outcomes.
Best Hospitals for Cervical Cancer Treatment in Bangalore
| Hospital | Key Strength |
|---|---|
| HCG Cancer Centre, Bangalore | India’s largest dedicated cancer network, advanced brachytherapy (Elekta Microselectron), robotic surgery, gynaecologic oncology specialists |
| Apollo Hospitals, Bannerghatta Road | TrueBeam radiation, robotic hysterectomy, comprehensive gynaecologic oncology |
| Manipal Hospital, Old Airport Road | Gynaecologic oncology, advanced radiation, laparoscopic surgery |
| Fortis Hospital, Bannerghatta Road | Experienced gynaecologic oncologists, advanced radiation oncology |
| Narayana Health — Mazumdar Shaw | Affordable high-quality treatment, advanced radiation |
| Sri Shankara Cancer Hospital | Dedicated cancer centre, brachytherapy, gynaecologic oncology |
| Cytecare Hospitals | Specialised cancer hospital, advanced technology |
Pap Smear Screening — Who Should Get Screened and When
| Age Group | Screening Recommendation |
|---|---|
| Under 21 | No routine screening recommended |
| 21 – 29 years | Pap smear every 3 years |
| 30 – 65 years | Pap smear + HPV test every 5 years (preferred) OR Pap smear alone every 3 years |
| Over 65 | Can stop screening if previous tests normal (discuss with doctor) |
| After hysterectomy | Can stop if cervix removed and no history of pre-cancer |
Important for Indian women: Given India’s low screening rate and high cervical cancer burden, all sexually active women should discuss screening with their doctor regardless of age and symptoms.
Can Cervical Cancer Be Prevented?
Yes — more completely than almost any other cancer. The combination of HPV vaccination and regular screening can prevent the vast majority of cervical cancer cases.
Prevention Strategy:
- HPV Vaccination — ideally before first sexual exposure, but beneficial at any age up to 45
- Regular Pap Smear — every 3 years from age 21
- HPV DNA Testing — every 5 years from age 30
- Quit smoking — reduces risk significantly if HPV-positive
- Healthy immune system — manage HIV and other immune-compromising conditions
- Use condoms — reduces (but does not eliminate) HPV transmission risk
How Doctor Visit Bangalore Can Help
At Doctor Visit Bangalore, we are committed to making cervical cancer screening, diagnosis and treatment accessible to every woman in Bangalore — and to international patients seeking the best care at the most affordable cost.
We help you:
✅ Book a Pap smear or HPV screening test at the right centre in Bangalore
✅ Find the best gynaecologic oncologist in Bangalore for your stage and situation
✅ Get a second opinion before committing to a treatment plan
✅ Understand your diagnosis and treatment options in simple, clear language
✅ Compare hospitals and costs transparently — no hidden charges
✅ Support for international patients — visa assistance, airport pickup, accommodation
✅ Arrange HPV vaccination for you and your family
✅ 24/7 WhatsApp support throughout your care journey.
📞 Call / WhatsApp: +91 78920 28951 🌐 www.doctorvisitbangalore.com
Frequently Asked Questions
Q: What is the most common cause of cervical cancer in India? Persistent infection with high-risk HPV strains — particularly HPV 16 and HPV 18 — causes approximately 95% of all cervical cancers in India. HPV 16 and 18 together account for about 70% of cases.
Q: Is cervical cancer curable? Yes — particularly when detected early. Stage 1 cervical cancer has a 5-year survival rate of over 90%. Even Stage 2 has a survival rate of 58-75% with appropriate treatment. Early detection through regular screening is the key to cure.
Q: Can a woman who has never had sex get cervical cancer? It is extremely rare. Since virtually all cervical cancer is caused by HPV — a sexually transmitted virus — women who have never been sexually active have a very low risk. However, it is not impossible, and other factors may very rarely play a role.
Q: At what age should Indian women start Pap smear screening? Indian guidelines recommend starting Pap smear screening at age 21, or within 3 years of first sexual activity. HPV testing is added from age 30. Given India’s high cervical cancer burden, do not delay starting screening.
Q: Is the HPV vaccine safe? Yes. The HPV vaccine is one of the most extensively studied vaccines in history. It is safe, effective and recommended by the WHO, Indian government, and all major medical organisations. It does not cause infertility — a common myth that has unfortunately prevented many girls from receiving the vaccine.
Q: Can cervical cancer affect fertility? Early-stage cervical cancer treated with trachelectomy (fertility-sparing surgery) may allow a woman to become pregnant later. Hysterectomy removes the uterus and ends the possibility of pregnancy. Radiation therapy to the pelvis also affects fertility. These are important discussions to have with your doctor before starting treatment.
Q: What is the difference between a Pap smear and an HPV test? A Pap smear looks for abnormal cervical cells — it detects changes that have already occurred. An HPV test looks for the presence of high-risk HPV virus — it detects the infection before cell changes even develop. Both are used in cervical cancer screening and are complementary tests.
Q: Can men spread HPV and contribute to cervical cancer risk? Yes. HPV is transmitted between sexual partners. Men can carry and transmit high-risk HPV strains without any symptoms or health consequences to themselves. This is why male HPV vaccination is also now recommended — to reduce transmission and protect all partners.
Q: How do I book a cervical cancer screening or specialist consultation in Bangalore? Doctor Visit Bangalore can help you book a Pap smear, HPV test or gynaecologist consultation at the best hospitals and clinics in Bangalore — quickly and easily. Contact us at +91 78920 28951.
Final Thoughts — A Preventable Tragedy That Does Not Have to Continue
One woman dying every seven minutes. 77,000 lives lost every year. A cancer that is almost entirely preventable.
This does not have to be India’s story.
The HPV vaccine works. Regular screening works. Early treatment works. The tools to eliminate cervical cancer exist — and Bangalore has some of the finest gynaeco
logic oncologists and cancer centres in Asia to deliver that treatment.
What is needed now is awareness. Conversation. Action.
If you have not been screened — book a Pap smear. If your daughter has not been vaccinated — arrange an HPV vaccine. If you have any of the symptoms described in this guide — see a doctor today.
Cervical cancer does not have to kill another Indian woman. Not when we have the knowledge and the tools to prevent it.
Doctor Visit Bangalore is here to help you take that first step.
📞 Call / WhatsApp: +91 78920 28951 🌐 www.doctorvisitbangalore.com
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Please consult a qualified gynaecologist or gynaecologic oncologist for diagnosis, screening and treatment of cervical cancer.
Arman Ali is the founder of Doctor Visit Bangalore, a trusted healthcare navigation platform helping patients find verified doctors, hospitals, and specialists across Bangalore and all over in India. With hands-on experience in healthcare research and patient assistance, Arman has personally helped hundreds of domestic and international patients connect with leading hospitals including Apollo, Manipal, Fortis, and Aster. His content is grounded in real hospital data, treatment cost research, and direct coordination with medical professionals across Bangalore. He specializes in medical tourism guidance, treatment cost transparency, and specialist discovery for complex conditions including cancer, cardiac surgery, and orthopedic care.
